Tango Therapeutics, Inc. · NASDAQ:TNGX

Dapice Joshua J. reported a 8.40% stake in Tango Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 13, 2025

Dapice Joshua J. reported a 8.40% stake in Tango Therapeutics, Inc., 9,157,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G/A).

Stake
8.40%
Shares
9,157,000
Intent
Passive
What changed
Stake changed
Filed together
28 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.1.40%1,490,990
Farallon Capital Institutional Partners, L.P.1.90%2,023,027
Farallon Capital Institutional Partners II, L.P.0.50%492,541
Farallon Capital Institutional Partners III, L.P.0.30%351,042
Four Crossings Institutional Partners V, L.P.0.40%428,510
Farallon Capital Offshore Investors II, L.P.3.50%3,754,671
Farallon Capital F5 Master I, L.P.0.30%358,666
Farallon Capital (AM) Investors, L.P.0.20%257,553
Farallon Partners, L.L.C.8.10%8,798,334
Farallon Institutional (GP) V, L.L.C.0.40%428,510
Farallon F5 (GP), L.L.C.0.30%358,666
Dapice Joshua J.8.40%9,157,000
Dreyfuss, Philip D.8.40%9,157,000
Dunn Hannah E.8.40%9,157,000
Fried, Richard B8.40%9,157,000
Gehani, Varun N.8.40%9,157,000
Giauque, Nicolas8.40%9,157,000
Kim, David T.8.40%9,157,000
Linn, Michael G.8.40%9,157,000
Luo Patrick (Cheng)8.40%9,157,000
Patel, Rajiv A.8.40%9,157,000
Roberts, Jr., Thomas G.8.40%9,157,000
Saito Edric C.8.40%9,157,000
Seybold, William8.40%9,157,000
Short Daniel S.8.40%9,157,000
Spokes, Andrew J. M.8.40%9,157,000
Warren, John R.8.40%9,157,000
Wehrly, Mark C.8.40%9,157,000

Source

View original at SEC

Related